Since PF-06747143 was shown to be a potent inhibitor of cytoskeletal organization, we evaluated its ability to inhibit CLL-B cell migration driven by its ligand, CXCL12, using a transwell migration assay. The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.